2.Relationship between Chlamydia Pneumoniae Infection and Changes of Coronary Artery in Children
guo-hong, ZHU ; xing-er, BAO ; fang, YE ; zhi-min, CHEN ; li-qin, CHEN
Journal of Applied Clinical Pediatrics 2006;0(16):-
Objective To explore whether chlamydia pneumoniae(CP) infection causes the coronary artery morphology change in children and their reciprocity.Methods Serum immunoglobin M(IgM) and immunoglobin G(IgG) antibody to CP were detected by enzymelinked immunosorbent assay(ELISA) in 52 hospitalized children aged 1 month to 10 years and 5 months old in respiratory ward in our hospital,serum interleukin-6(IL-6),triglyceride(TG) and peripheral blood C-reactive protein(CRP) were also determined,morphology change of coronary artery of the patients were harvested by colored doppler echocardiogram.Results In the 52 cases,21 cases were positive of IgM,28 cases were positive of IgG,3 cases were positive both IgM and IgG.Twelve cases were high of CRP,5 cases were high of IL-6,9 cases were high of TG.In the 52 patients,the different levels of IgM,IgG,IL-6,CRP and TG had not coronary artery morphology change.Conclusion CP infection in the children does not cause the coronary artery to occur morphology change.
3.Effect of batimastat on the dynamic changes of matrix metalloproteinases in liver tissue during the development of hepatocellular carcinoma in rats.
Yi GAO ; Zhi ZHANG ; Ze-sheng JIANG ; Shi-gang FANG ; Er-wei SUN ; Jing LIU ; Bao-hua CHEN
Chinese Journal of Hepatology 2003;11(9):570-571
Animals
;
Carcinoma, Hepatocellular
;
enzymology
;
Liver
;
enzymology
;
Liver Neoplasms
;
enzymology
;
Matrix Metalloproteinase 2
;
metabolism
;
Matrix Metalloproteinase 9
;
metabolism
;
Phenylalanine
;
analogs & derivatives
;
pharmacology
;
Protease Inhibitors
;
pharmacology
;
Rats
;
Rats, Wistar
;
Thiophenes
;
pharmacology
4.Expression of AML1/ETO9a isoform in acute myeloid leukemia-M2 subtype.
Yu-qing MIAO ; Zi-xing CHEN ; Jun HE ; Jian-nong CEN ; Xiao-jing BAO ; Qiao-cheng QIU ; Dong-er ZHANG ; Ming YAN
Chinese Journal of Hematology 2007;28(1):27-29
OBJECTIVETo investigate the expression of AML1/ETO9a isoform in the acute myeloid leukemia (AML)-M2 patients.
METHODSExpressions of AML1/ETO fusion gene and AML1/ETO9a isoform were detected by using reverse transcriptase-polymerase chain reaction (RT-PCR) in leukemia patients, MDS patients, leukemia cell lines and healthy subjects. Karyotype was studied by R-banding technique.
RESULTIn 30 newly diagnosed AML-M2 patients 15 were found to express AML1/ETO9a isoform, while the rest including 20 AML-M2CR, 18 other subtypes of AML, 5 chronic myelogenous leukemia (CML), 3 myelodysplastic syndromes (MDS), 3 leukemia cell lines (NB4, KG-1, K562) and 5 healthy subjects were AML1/ETO9a negative. Among the 15 AML/ETO9a isoform expressing cases, 13 were demonstrated t(8;21) translocation and AML1/ETO expression.
CONCLUSIONIsoform AML1/ETO9a was correlated to AML/M2, and it may promote the development of leukemia in combination with the AML1/ETO fusion gene.
Adolescent ; Adult ; Aged ; Core Binding Factor Alpha 2 Subunit ; genetics ; metabolism ; Female ; Gene Expression ; Humans ; Karyotyping ; Leukemia, Myeloid, Acute ; genetics ; metabolism ; Male ; Middle Aged ; Oncogene Proteins, Fusion ; genetics ; metabolism ; Protein Isoforms ; genetics ; metabolism ; RUNX1 Translocation Partner 1 Protein
5.Cytotoxicity and mechanism of 23-O-acetylcimigenol-3-O-beta-D-xylopyranoside on HepG2 cells.
Zel TIAN ; Jian-Yong SI ; Si-Bao CHEN ; Meng-Su YANG ; Pei-Gen XIAO ; Er-Xi WU
China Journal of Chinese Materia Medica 2006;31(21):1818-1821
OBJECTIVETo elucidate the cytotoxicity and mechanism of 23-O-acetylcimigenol-3-O-beta-D-xylopyranoside isolated from C. dahurica on HepG2 cells and to find the leading compound for new drug development.
METHODMTT, AO/EB staining observation, flow cytometry and western blot methods were used to study the cytotoxicity, morphological changes, cell cycle distribution and protein expression profile of 23-O-acetylcimigenol-3-O-beta-D-xylopyranoside on HepG2 cells.
RESULT23-O-acetylcimigenol-3-O-beta-D-xylopyranoside could inhibit the proliferation of HepG2 cells with IC50 at 16 micromol x L(-1), and could also induce apoptosis and G2-M cell cycle arrest. Further study demonstrated that the compound could cleavage PARP, regulate protein expression of bcl-2 family and decrease the expression of cdc 2 and cyclin B.
CONCLUSION23-O-acetylcimigenol-3-O-beta-D-xylopyranoside exerts its cytotoxicity on HepG2 cells via apoptosis and G2-M arrest. In addition, caspases family activation, regulation of protein expression of bcl-2 family and down regulation of cdc 2 and cyclin B were involved in apoptosis and G2-M arrest induced by it.
Apoptosis ; drug effects ; CDC2 Protein Kinase ; metabolism ; Cell Cycle ; drug effects ; Cell Line, Tumor ; Cell Proliferation ; drug effects ; Cimicifuga ; chemistry ; Cyclin B ; metabolism ; Glycosides ; isolation & purification ; pharmacology ; Humans ; Liver Neoplasms ; metabolism ; pathology ; Plants, Medicinal ; chemistry ; Poly(ADP-ribose) Polymerases ; metabolism ; Proto-Oncogene Proteins c-bcl-2 ; metabolism ; Triterpenes ; isolation & purification ; pharmacology ; bcl-2-Associated X Protein ; metabolism
6.Genotypic study on the Helicobacter pylori vacA, cagA and iceA genes in the infected children in Guangzhou area.
Yan-fen LIN ; Si-tang GONG ; Wen-ji OU ; Rui-fang PAN ; Hai HUANG ; Wan-er HE ; Li-ying LIU ; Xiao-he HUO ; Bao-xin CHEN
Chinese Journal of Pediatrics 2007;45(9):703-707
OBJECTIVETo investigative vacA, cagA and iceA genes dominant genotypes of Helicobacter pylori (Hp) isolated from children suffering from gastric and duodenal diseases in Guangzhou area.
METHODSTotally 105 children who underwent gastroscopy in Guangzhou Children's Hospital were enrolled into this study. From each patient, 3 biopsy specimens from the gastric antrum were taken, one was used for rapid urease test, one for histological examination, and one for polymerase chain reaction (PCR) for detecting ureA, vacA, cagA, and iceA genes. DNA was prepared directly from the biopsy specimens from the gastric antrum using a QIAamp DNA mini kit (Qiagen, Germany) according to the manufacturer's instructions. Then 11 primers were used for detecting the genotypes including ureas, (s1, s1a, s1b, s1c, s2) and m (m1, m1T, m2) region of vacA, cagA and iceA (iceA1 and iceA2) genotypes in the 105 children. The distribution of the genotypes of Hp was analyzed.
RESULTAmong the 105 children, only 52 children were positive by the three methods, among these 52 children, 26 were boys and 26 girls. Hp vacA s1as1c/m2 was detected in 43 out of 52 children (82.7%), s1as1c/m1T in 9.6% (5/52), m region that could not betyped was 7.7% (4/52). No strains presented genotypes vacA s1b, s2, m1. The comparison of the positive ratio of vacA s1as1 c/m2 detected in the children infected with Hp and that of the other combination of signal region and middle region was statistically significantly different (P < 0.01). With regard to cagA gene, cagA(+) gene and cagA(-) gene were found in 90.4% (47/52) and 9.6% (5/52) of the children, respectively. The cagA(+) gene was more frequent in the children infected with Hp. Single iceA1 was detected in 78.8% (41/52) children, and single iceA2 was detected to be 1.9% (1/52), multiple strains infection of iceA1 and iceA2 were detected in 3.8% (2/52) children, iceA1 and iceA2 were not detected in 15.4% (8/52), the comparison of the positive ratio of iceA1 detected in the children infected with Hp and that of the other genotypes was statistically significantly different (P < 0.01).
CONCLUSIONThe s1as1c/m2, cagA and iceA1 were the dominant genotypes of Hp in the children in Guangzhou area and s1as1c/m2, cagA and iceA1 were the dominant genotypes combination of Hp in the children in this area.
Antigens, Bacterial ; genetics ; therapeutic use ; Bacterial Outer Membrane Proteins ; genetics ; Bacterial Proteins ; genetics ; Child ; China ; epidemiology ; Female ; Genes, Bacterial ; drug effects ; genetics ; Genotype ; Helicobacter Infections ; drug therapy ; genetics ; Helicobacter pylori ; genetics ; Humans ; Male ; Polymerase Chain Reaction ; Pyloric Antrum ; microbiology
7.Balloon dilation with gastroscope for esophageal stricture in children.
Lan-lan GENG ; Si-tang GONG ; Hai HUANG ; Wan-er HE ; Wen-ji OU ; Rui-fang PAN ; Xiao-he HUO ; Bao-xin CHEN
Chinese Journal of Pediatrics 2008;46(12):895-898
OBJECTIVETo evaluate the efficacy and safety of balloon dilation (BD) with gastroscope in treatment of esophageal stricture in children.
METHODSBD was performed in 12 children aged 5 - 59 months, average age 26 months, course of disease was 2 - 26 months, with esophageal stricture, 7 cases with anastomotic strictures secondary to surgical repair of esophageal atresia, 3 with congenital esophageal stenosis, 2 with corrosive esophageal strictures. All procedures were performed under tracheal intubation and intravenous anesthesia using the 3rd grade controlled radial expansion (CRE) esophagus-balloon with gastroscope. Firstly the balloon was inserted into the esophagus through mouth, then put in the gastroscope. Under the direct guidance of gastroscope the balloon was positioned across the stricture, then the balloon was filled with saline to get needed pressure and maintained for 3 minutes. The procedure was repeated 3 times at an interval of 3 minutes. The abdominal pain, melena and vomiting were observed, as well as the diet taken thereafter, the size of the stricture and the nutrition status were observed for 3 to 12 months after the dilation.
RESULTSTwenty-two dilations were performed in 12 cases, 19 succeeded, 3 cases developed complication during the dilation, the total success rate was 86%. The procedure failed in 3 cases and succeeded in 9 cases, the effective rate was 75%. Follow-up and repeated gastroscopy were performed within 3 to 12 months after the dilation, the diameter of the stricture was 9-13 mm, compared with 2-8 mm before the dilation. Eight of the children could take solid food and nutritional status was improved.
CONCLUSIONSBD with the 3rd grade CRE esophagus-balloon under gastroscopy is a simple and effective method to treat esophagus stricture in children, especially for anastomotic strictures secondary to surgical repair of esophageal atresia.
Catheterization ; methods ; Child, Preschool ; Esophageal Stenosis ; therapy ; Gastroscopes ; Humans ; Infant ; Treatment Outcome
8.The location and significance of heterogeneous nuclear ribonucleoprotein A 1 in hepatocellular carcinoma
Zheng-Jun ZHOU ; Xiao-Yi WANG ; Er-Bao CHEN ; Zhi-Qiang HU ; Shao-Lai ZHOU ; Jian ZHOU ; Jia FAN ; Zhi DAI
Chinese Journal of Clinical Medicine 2016;23(6):720-724
Objective:To investigate the location of heterogeneous nuclear ribonucleoprotein A 1 (hnRNP A1 ) ,and to analyze the relationship between the location and clinicopathologic feature and its prognostic significance in hepatocellular carcinoma (HCC) .Methods : The location of hnRNP A1 was studied in an independent cohort of 323 HCC patients by immunohistochemistry ,the hnRNP A1 location and clinicopathologic feature and its prognostic significance in HCC were concluded .Results:For hnRNP A1 ,there was weak‐to‐moderate intensity immunoreactivity with nuclear expression in normal liver ,while showed cytoplasmic and nuclear loaction in HCC .The cytoplasmic loaction of hnRNP A1 is significantly correlated with poor prognosis of HCC patients after operation .Conclusions :The hnRNP A1 is a great independent prognostic indicator , which can accurately predict the poor outcome of HCC patients after surgery .
9.Synergistic suppressive effect of PARP-1 inhibitor PJ34 and HDAC inhibitor SAHA on proliferation of liver cancer cells.
Bin-Yong LIANG ; Min XIONG ; Gui-Bao JI ; Er-Lei ZHANG ; Zun-Yi ZHANG ; Ke-Shuai DONG ; Xiao-Ping CHEN ; Zhi-Yong HUANG
Journal of Huazhong University of Science and Technology (Medical Sciences) 2015;35(4):535-540
Poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors and histone deacetylase (HDAC) inhibitors have recently emerged as promising anticancer drugs. The aim of this study was to investigate the effect of combination treatment with the PARP inhibitor PJ34 and HDAC inhibitor SAHA on the proliferation of liver cancer cells. Cell proliferation and apoptosis were assessed in three human liver cancer cell lines (HepG2, Hep3B and HCC-LM3) treated with PJ34 (8 μmol/L) and SAHA (1 μmol/L), alone or combined, by Cell Counting Kit-8 assay and flow cytometry, respectively. The nude mice bearing subcutaneous HepG2 tumors were administered different groups of drugs (10 mg/kg PJ34, 25 mg/kg SAHA, 10 mg/kg PJ34+25 mg/kg SAHA), and the inhibition rates of tumor growth were compared between groups. The results showed that combined use of PJ34 and SAHA could synergistically inhibit the proliferation of liver cancer cell lines HepG2, Hep3B and HCC-LM3. The apoptosis rate of HepG2 cells treated with PJ34+SAHA was significantly higher than that of HepG2 cells treated with PJ34 or SAHA alone (P<0.05). In vivo, the tumor inhibition rates were 53.5%, 61.4% and 82.6% in PJ34, SAHA and PJ34+SAHA groups, respectively. The combined use of PJ34 and SAHA could significantly inhibit the xenograft tumor growth when compared with use of PJ34 or SAHA alone (P<0.05). It was led to conclude that PJ34 and SAHA can synergistically suppress the proliferation of liver cancer cells.
Animals
;
Antineoplastic Combined Chemotherapy Protocols
;
administration & dosage
;
Cell Line, Tumor
;
Cell Proliferation
;
drug effects
;
Drug Synergism
;
Hep G2 Cells
;
Histone Deacetylase Inhibitors
;
administration & dosage
;
pharmacology
;
Humans
;
Hydroxamic Acids
;
administration & dosage
;
pharmacology
;
Liver Neoplasms
;
drug therapy
;
Mice
;
Phenanthrenes
;
administration & dosage
;
pharmacology
;
Poly(ADP-ribose) Polymerase Inhibitors
;
administration & dosage
;
pharmacology
;
Xenograft Model Antitumor Assays
10.Preparation and identification of a polyclonal antibody against novel cysteinyl leukotriene receptor GPR17.
Ling-ling QI ; Yun-bi LU ; Wen-zhen SHI ; Chun-zhen ZHAO ; Yong-mei ZHANG ; Li-ping CHEN ; Li-hui ZHANG ; San-hua FANG ; Jian-fang BAO ; Jian-gen SHEN ; Er-qing WEI
Journal of Zhejiang University. Medical sciences 2009;38(4):357-361
OBJECTIVETo prepare and identify a polyclonal antibody (pAb) against GPR17, a novel cysteinyl leukotriene receptor.
METHODSRabbits were immunized with KLH-coupled GPR17 peptide to prepare the pAb. The titer of the pAb in rabbit plasma was detected by indirect ELISA, and the specificity of the pAb was tested by antigen blockade. GPR17 tissue distribution was detected by Western blot with the pAb.
RESULTSThe pAb showed a titer as high as 1:16 364,and was not cross-reacted with the antigens of CysLT(1) and CysLT(2) receptors. A higher expression of GPR17 in the rat brain and heart was detected using the newly prepared pAb. The molecular weigh of GPR17 protein was about 43 kD.
CONCLUSIONThe prepared GPR17 pAb has high sensitivity and specificity,and can be used in Western blot for detecting GPR17.
Animals ; Antibodies, Monoclonal ; biosynthesis ; immunology ; Enzyme-Linked Immunosorbent Assay ; Humans ; Rabbits ; Rats ; Receptors, G-Protein-Coupled ; immunology ; Receptors, Leukotriene ; immunology